Exploring gaps in GLP-1 research, care, and coverage
Update: 2024-11-11
Description
GLP-1 drugs, like Ozempic, Wegovy, and Zepbound, have gained attention for their significant health impacts and anti-obesity effects. However, there continues to be a lot of unknowns surrounding these medications, their long-term impacts, and access.
Featuring: Dr. Lydia Alexander, an obesity medicine specialist, lifestyle specialist, president of the Obesity Medicine Association (OMA), Chief Medical Officer at Enara, and a medical chef.
In today’s episode, we’ll cover
- The significant progress made in GLP-1 research, care delivery, and insurance coverage
- Filling research gaps in GLP-1 care through longitudinal studies examining long-term medication effects and potential adverse reactions
- Tips for providers managing patients on GLP-1 medications and patient-focused approaches to obesity management
And more!
To watch video clips from our podcast, subscribe to our YouTube channel, @Healthcare Strategies
Resources:
Comments
Top Podcasts
The Best New Comedy Podcast Right Now – June 2024The Best News Podcast Right Now – June 2024The Best New Business Podcast Right Now – June 2024The Best New Sports Podcast Right Now – June 2024The Best New True Crime Podcast Right Now – June 2024The Best New Joe Rogan Experience Podcast Right Now – June 20The Best New Dan Bongino Show Podcast Right Now – June 20The Best New Mark Levin Podcast – June 2024
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
